JR-220

N/A

Report date: 2025/01/26 18:12:30
NME

Base Information

Drug NameJR-220
Drug Alias NameNMDA receptor modulator (University of Kentucky)iminoguanidine compound (University of Kentucky)JR-220
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A

Develop Information

Active CompaniesNaprogenix Inc
Inactive CompaniesUniversity Of Kentucky
Active IndicationsAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A